Total Payments
$693.94
2023 Payments
$13.72
Companies
17
Transactions
45
Medicare Patients
56
Medicare Billing
$2,326
Payment Breakdown by Category
Food & Beverage$693.94 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $693.94 | 45 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $152.45 | 11 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $89.36 | 5 | $0 (2019) |
| Mylan Pharmaceuticals Inc. | $54.71 | 4 | $0 (2018) |
| Astellas Pharma US Inc | $46.96 | 3 | $0 (2019) |
| Amgen Inc. | $41.79 | 3 | $0 (2022) |
| Pacira Pharmaceuticals Incorporated | $40.96 | 3 | $0 (2022) |
| TherapeuticsMD, Inc. | $40.86 | 2 | $0 (2019) |
| Allergan Inc. | $39.12 | 2 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $38.45 | 3 | $0 (2018) |
| PFIZER INC. | $27.91 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $13.72 | 1 | Hologic Sales and Service, LLC ($13.72) |
| 2022 | $39.72 | 3 | Amgen Inc. ($18.03) |
| 2021 | $97.82 | 6 | AbbVie Inc. ($51.63) |
| 2020 | $49.05 | 3 | AbbVie Inc. ($25.61) |
| 2019 | $207.21 | 12 | Merck Sharp & Dohme Corporation ($52.77) |
| 2018 | $194.32 | 14 | AbbVie, Inc. ($62.30) |
| 2017 | $92.10 | 6 | Roche Diagnostics Corporation ($23.97) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/19/2023 | Hologic Sales and Service, LLC | MYOSURE TISSUE REMOVAL DEVICE (Device), OMNI HYSTEROSCOPE, ACESSA PROVU SYSTEM | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Surgical | ||||||
| 06/07/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Bone Health | ||||||
| 04/29/2022 | Meditrina | Aveta (Device) | Food and Beverage | Cash or cash equivalent | $9.16 | General |
| Category: Gynecology | ||||||
| 03/29/2022 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: Pain Management | ||||||
| 11/16/2021 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Pain Management | ||||||
| 10/13/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: Bone Health | ||||||
| 08/26/2021 | AbbVie Inc. | ORILISSA (Drug), ORIAHNN | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: WOMENS HEALTH | ||||||
| 08/24/2021 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: WOMENS HEALTH | ||||||
| 07/20/2021 | Myovant Sciences Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: HORMONE THERAPY | ||||||
| 05/20/2021 | AbbVie Inc. | ORILISSA (Drug), ORIAHNN | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: WOMENS HEALTH | ||||||
| 09/22/2020 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: WOMENS HEALTH | ||||||
| 08/25/2020 | AbbVie Inc. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: WOMENS HEALTH | ||||||
| 02/20/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Obesity | ||||||
| 09/17/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/07/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: Bone Health | ||||||
| 07/09/2019 | Allergan Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: WOMENS HEALTH | ||||||
| 06/27/2019 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug), GARDASIL9 | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: WOMENS HEALTH | ||||||
| 04/16/2019 | TherapeuticsMD, Inc. | IMVEXXY (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: OBSTETRICSGYNECOLOGY WOMEN'S HEALTH | ||||||
| 04/08/2019 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug), GARDASIL9 | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: WOMENS HEALTH | ||||||
| 03/18/2019 | Allergan Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: WOMENS HEALTH | ||||||
| 03/15/2019 | TherapeuticsMD, Inc. | IMVEXXY (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: OBSTETRICSGYNECOLOGY WOMEN'S HEALTH | ||||||
| 03/11/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: UROLOGY | ||||||
| 02/07/2019 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug), GARDASIL9 | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: WOMENS HEALTH | ||||||
| 01/23/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Endocrinology | ||||||
| 01/16/2019 | Hologic, LLC | myosure (Device), FLUENT | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Surgical | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 19 | 19 | $2,109 | $722.95 |
| 2022 | 2 | 37 | 37 | $5,053 | $1,603 |
Total Patients
56
Total Services
56
Medicare Billing
$2,326
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 19 | 19 | $2,109 | $722.95 | 34.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 14 | 14 | $2,623 | $850.06 | 32.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 11 | 11 | $1,158 | $426.13 | 36.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Facility | 2022 | 12 | 12 | $1,272 | $326.84 | 25.7% |
About Dr. James Pate, MD
Dr. James Pate, MD is a Obstetrics & Gynecology healthcare provider based in Saranac Lake, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2009. The National Provider Identifier (NPI) number assigned to this provider is 1639311277.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Pate, MD has received a total of $693.94 in payments from pharmaceutical and medical device companies, with $13.72 received in 2023. These payments were reported across 45 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($693.94).
As a Medicare-enrolled provider, Pate has provided services to 56 Medicare beneficiaries, totaling 56 services with total Medicare billing of $2,326. Data is available for 2 years (2022–2023), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Obstetrics & Gynecology
- Location Saranac Lake, NY
- Active Since 03/27/2009
- Last Updated 07/21/2022
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1639311277
Products in Payments
- NEXPLANON (Drug) $89.36
- LO LOESTRIN FE (Drug) $63.18
- Xulane (Drug) $54.71
- ORILISSA (Drug) $53.18
- Orilissa (Drug) $50.46
- EVENITY (Biological) $41.79
- IMVEXXY (Drug) $40.86
- Exparel (Drug) $27.50
- MYRBETRIQ (Drug) $27.32
- RS Harmony Test Related Products (Device) $23.97
- Saxenda (Drug) $23.44
- Kyleena (Drug) $22.70
- myosure (Device) $20.92
- Myrbetriq (Drug) $19.64
- MYFEMBREE (Drug) $19.14
- Natazia (Drug) $15.75
- DUAVEE (Drug) $14.77
- MYOSURE TISSUE REMOVAL DEVICE (Device) $13.72
- EXPAREL (Drug) $13.46
- PREMARIN ORALS (Drug) $13.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.